Biopharmaceuticals
Regulatory
News Release - June 11, 2007
Bosentan (Tracleer) Receives EU Approval for Reduction of Number of New Digital Ulcerations in Systemic Sclerosis Patients
Source: Actelion
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.